enterade® may help your patients live without the debilitating impact of NETs-related diarrhoea.

What is enterade® ?
enterade® is the first and only glucose-free medical food, specifically designed to address NETs related diarrhoea.

Developed by oncologists and gastroenterologists.

Utilises a proprietary Amino Acid Coupled Transport Technology (A₂CT™) which contains a combination of five critical amino acids (Valine, Aspartic Acid, Serine, Threonine, Tyrosine) and electrolytes (potassium and sodium). This patented combination uniquely addresses the core contributors to NETs-related diarrhoea, dehydration, and compromised GI functioning.

How does enterade work?

  • enterade® tightens barrier junctions between cells in the GI tract, improving barrier function
  • enterade® helps to rebuild damaged villi
  • enterade® achieves total body hydration

Based on a pilot study, adding enterade® to your supportive care protocol may significantly reduce diarrhoea in NETs patients. 1

In a pilot study of enterade®, 33 neuroendocrine tumour patients with quality of life limiting diarrhoea, 76% of patients reported subjective improvement in diarrhoeal symptoms within one week, and 59% of responders reported at least 50% reduction in diarrhoea frequency after only one week of treatment. 1

Download pilot study here


Where can patients get enterade®?

enterade® is available without a prescription but should be used under the direction of your healthcare professional. Patients can order enterade at www.auroradirect.com.au

Product information

  • Typical use of enterade® is two bottles per day. 30 minutes before or 1 hour after consuming food.
  • Patients prefer enterade® chilled or over ice.
  • Do not mix enterade® with other products.
  • Refrigerate after opening.
  • The efficacy of enterade® will depend on your patient’s condition and severity of symptoms experienced.
  • In a pilot study patients reported a reduction in symptoms after drinking enterade® in as little as 7 days. 1

1Chauhan, A., Miller, R.,Yu, Qian, Y., Luque, L., Weiss, H., Lowell, B.A. (2018) The Anti-Diarrheal Efficacy of an Amino Acid Mixture in Neuroendocrine Tumor (NET) Patients. GI ASCO Abstract.